Recruiting

Observational Study

Sponsor:

Banner Health

Code:

NCT02022943

Conditions

Alzheimer's Disease

Dementia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org

Conditions

Alzheimer's Disease

Dementia

Study ID

NCT02022943

Start date

May, 2012

Status verified date

Dec, 2025

Completion date

Jan, 2030

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Must be able to accept the Alzheimer's Prevention Registry website terms and conditions

Exclusion Criteria:

  • None

Study Design

Enrollment

500000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Number of individuals enrolled into Alzheimer's prevention studies [ Time Frame: 16 years ]

Central Contacts and Locations

Central contacts

Locations

Banner Alzheimer's Institute

Recruiting

Phoenix, Arizona, United States, 85006

Principal Investigator:

Jessica Langbaum, PhD

More Information

Sponsor

Banner Health

Last update posted

Dec 16, 2025

Last verified

Dec, 2025

Keywords

  • Alzheimer's
  • prevention

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-12. This information was provided to ClinicalTrials.gov by Banner Health on 2025-12-16.